“…Some studies reported regional cerebral atrophy in frontal, parietal, and temporal lobes (Brenneis et al., 2003; Goel et al., 2011; Hernandez‐Castillo et al., 2015; Mercadillo et al., 2014; Nave, Ginestroni, Tessa, Salvatore et al., 2008), while some studies found brain volume reductions limited in the infratentorial regions such as cerebellum and pons (D'Agata, Caroppo, Boghi et al., 2011; Jacobi et al., 2013; Nave, Ginestroni, Tessa, Cosottini et al., 2008; Olivito et al., 2018). The atrophy of mesencephalon and thalamus was also detected in a few studies (Brenneis et al., 2003; Nave, Ginestroni, Tessa, Salvatore et al., 2008), and significant parahippocampal atrophy was demonstrated in one study (Mercadillo et al., 2014). Although all of these neuroimaging studies reported GM and WM volume reductions in the cerebellum in SCA2, the neurological hallmark for SCAs, the predominant side and regions of cerebellum involved were inconsistent.…”